These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 14133395

  • 41. [INDICATIONS AND CONTRAINDICATIONS FOR CORTISOL AND ITS DERIVATIVES IN PEDIATRICS].
    JACCOTTET M.
    Rev Med Suisse Romande; 1964 Jan; 84():14-28. PubMed ID: 14134786
    [No Abstract] [Full Text] [Related]

  • 42. [Assessment of adrenal function on steroid using renal diseases in children using the modified original ACTH tolerance test: comparing nephrotic syndrome with non-nephrotic syndrome].
    Tsuji Y, Mizuno Y, Iikura Y, Sakai T.
    Nihon Jinzo Gakkai Shi; 1999 Apr; 41(2):65-9. PubMed ID: 10361421
    [Abstract] [Full Text] [Related]

  • 43. Repository Corticotropin Versus Glucocorticoid for Nephrotic Syndrome: When Will We See the Evidence?
    Hartung DM, Johnston K, Deodhar A, Bourdette DN, Cohen DM.
    Am J Kidney Dis; 2019 Aug; 74(2):256-262. PubMed ID: 30765104
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Case-control study of subconjunctival triamcinolone acetonide injection vs intravenous methylprednisolone pulse in the treatment of endothelial corneal allograft rejection.
    Costa DC, de Castro RS, Kara-Jose N.
    Eye (Lond); 2009 Mar; 23(3):708-14. PubMed ID: 18820657
    [Abstract] [Full Text] [Related]

  • 46. A randomized pilot trial comparing methylprednisolone plus a cytotoxic agent versus synthetic adrenocorticotropic hormone in idiopathic membranous nephropathy.
    Ponticelli C, Passerini P, Salvadori M, Manno C, Viola BF, Pasquali S, Mandolfo S, Messa P.
    Am J Kidney Dis; 2006 Feb; 47(2):233-40. PubMed ID: 16431252
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Glucocorticoids for parenteral administration.
    Med Lett Drugs Ther; 1965 Dec 31; 7(27):111-2. PubMed ID: 4285249
    [No Abstract] [Full Text] [Related]

  • 50. Use of 6-methylprednisolone (Medrol) in the treatment of nephrosis in children.
    LARON Z, YONIS Z, GEIFMAN M, GARTY R.
    Helv Paediatr Acta; 1961 Apr 31; 16():104-9. PubMed ID: 13759153
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. [PROBLEMS IN THE SIDE-EFFECTS OF ADRENAL CORTEX HORMONE THERAPY OF SKIN DISEASES].
    NOHARA N, TSUKINOKI K, TODA M.
    Nisshin Igaku Jpn J Med Prog; 1963 Mar 31; 50():139-58. PubMed ID: 14058448
    [No Abstract] [Full Text] [Related]

  • 56. [Treatment with superhigh corticosteroid doses (pulse therapy) of patients with the idiopathic nephrotic syndrome].
    Tishkov I, Popov R.
    Vutr Boles; 1987 Mar 31; 26(2):27-33. PubMed ID: 3604193
    [Abstract] [Full Text] [Related]

  • 57. Triamcinolone and methyl prednisolone in psoriasis. Comparison of their intralesional and systemic effects.
    COHEN HJ, BAER RL.
    J Invest Dermatol; 1960 Apr 31; 34():271-5. PubMed ID: 13810959
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. MANAGEMENT OF RHEUMATOID DISEASE IN CHILDHOOD.
    SCHLESINGER B.
    Proc R Soc Med; 1964 Jan 31; 57(1):62-4. PubMed ID: 14114180
    [No Abstract] [Full Text] [Related]

  • 60. Comparison of the effects of intravenous methylprednisolone pulse versus oral prednisolone therapies on the first attack of minimal-change nephrotic syndrome in adults.
    Fukudome K, Fujimoto S, Sato Y, Kitamura K.
    Nephrology (Carlton); 2012 Mar 31; 17(3):263-8. PubMed ID: 22117558
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.